Lannett Company Inc (NYSE MKT LLC:LCI)
During the Trading Day
| 12.11 |  +0.34 / +2.89% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 12.11 |  0.00 / 0.00% |
Volume: 803.00 |
Latest LCI News | Press Releases
No recent news for Lannett Company Inc.
Today’s Trading
| Previous close | 11.77 |
| Today’s open | 11.78 |
| Day’s range | 11.67 - 12.17 |
| Volume | 64,650 |
| Average volume (3 months) | 131,941 |
| Market cap | $337.6M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +182.14% |
| Earnings growth (next 5 years) | +22.50% |
| Revenue growth (last year) | +14.84% |
| P/E ratio | 31.1 |
| Price/Sales | 0.97 |
| Price/Book | 2.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RPRXRepros Therapeutics ... | +1.26 | +7.03% |
| NAVBNavidea Biopharmaceu... | -0.03 | -1.12% |
| OMTHOmthera Pharmaceutic... | -0.11 | -0.84% |
| RGLSRegulus Therapeutics... | +0.03 | +0.30% |
Data as of 4:03pm ET, 06/18/2013
Financials
| Next reporting date | September 11, 2013 |
| EPS forecast (this quarter) | $0.07 |
| Annual revenue (last year) | $123.0M |
| Annual profit (last year) | $3.9M |
| Net profit margin | 3.21% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
President, CEO, Director & Head-Investor Relations Arthur P. Bedrosian |
Chief Operating Officer William F. Schreck |
Corporate headquarters Philadelphia, Pennsylvania |
Forecasts
